Last Updated:
Name Designation Appointment Date Status
Meenakshi Shrivastava

Appointed as Director since September 2023

Director 14-Sep-2023 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Pandora Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Shivangi Shrivastava

Appointed as Director since September 2022

Director 19-Sep-2022 Current
Nimisha Shrivastava

Appointed as Additional Director since April 2023

Additional Director 12-Apr-2023 Current

People Timeline

Explore the timeline of key personnel in Pandora Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address C/O Shivangi Shrivastav, Ward No. 22 Near Hanuman Mandir, Gharolla, Shahdol Madhya Pradesh, 484001, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 484001
  • Country India
  • Website -
Frequently Asked Questions
You can contact Pandora Pharmaceuticals Private Limited through their registered address at C/O Shivangi Shrivastav, Ward No. 22 Near Hanuman Mandir, Gharolla, Shahdol Madhya Pradesh, 484001, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Pandora Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MEENAKSHI SHRIVASTAVA
  • SHIVANGI SHRIVASTAVA
  • NIMISHA SHRIVASTAVA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available